Cargando…

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination

BACKGROUND: There is an urgent need to develop new innovative therapies for the control of advanced cancer. The combination of antigen-specific immunotherapy with the employment of immunomodulatory agents has emerged as a potentially plausible approach for the control of advanced cancer. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuang, Chi-Mu, Monie, Archana, Hung, Chien-Fu, Wu, T-C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873498/ https://www.ncbi.nlm.nih.gov/pubmed/20426849 http://dx.doi.org/10.1186/1423-0127-17-32

Ejemplares similares

Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
por: Chuang, Chi-Mu, et al.
Publicado: (2009)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
por: Wu, Chao-Yi, et al.
Publicado: (2010)

Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination
por: Tseng, Chih-Wen, et al.
Publicado: (2008)

Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation
por: Sun, Yunyan, et al.
Publicado: (2017)

Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008)

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015)

Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
por: Lee, Sung Yong, et al.
Publicado: (2019)

Depletion of platelets enhances therapeutic antitumor effects generated by therapeutic DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2013)

Enhancing DNA vaccine potency by co-administration of xenogenic MHC-class-I DNA
por: Kang, Tae Heung, et al.
Publicado: (2009)

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010)

Efficient Delivery of DNA Vaccines using Human Papillomavirus Pseudovirions
por: Peng, Shiwen, et al.
Publicado: (2010)

Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
por: Tahamtan, Alireza, et al.
Publicado: (2014)

Perspectives for therapeutic HPV vaccine development
por: Yang, Andrew, et al.
Publicado: (2016)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014)

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
por: Yang, Andrew, et al.
Publicado: (2017)

In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination
por: Mao, Chih-Ping, et al.
Publicado: (2011)

Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors
por: Sun, Y, et al.
Publicado: (2015)

Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
por: Tseng, Ssu-Hsueh, et al.
Publicado: (2021)

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Strategies for Enhancing Vaccine-Induced CTL Antitumor Immune Responses
por: Yong, Xin, et al.
Publicado: (2012)

Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector
por: Peng, Shiwen, et al.
Publicado: (2023)

Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine
por: Gan, Lili, et al.
Publicado: (2014)

Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant
por: Yang, Ming-Chieh, et al.
Publicado: (2016)

Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8(+) T cell immune response and antitumor effects in a preclinical cervical cancer model
por: Huang, Zhuomin, et al.
Publicado: (2015)

Innovative DNA Vaccine for Human Papillomavirus (HPV)-Associated Head and Neck Cancer
por: Wu, Annie, et al.
Publicado: (2010)

Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip
por: Pentangelo, Giovanni, et al.
Publicado: (2021)

Antitumor Effects of HPV DNA Vaccine Adjuvanted with Beclin-1 as an Autophagy Inducer in a Mice Model
por: Naziri, Hamed, et al.
Publicado: (2019)

Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
por: Mai, Junhua, et al.
Publicado: (2021)

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
por: Weir, Genevieve M, et al.
Publicado: (2014)

Antitumor Immunity from Abdominal Flap-Embedded Therapeutic Cancer Vaccine
por: Liu, Xiaoling, et al.
Publicado: (2022)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides
por: Li, Hsin-Ju, et al.
Publicado: (2020)

Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity
por: Tseng, Ssu-Hsueh, et al.
Publicado: (2022)

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
por: Peng, Shiwen, et al.
Publicado: (2016)

Therapeutic Vaccines for HPV-Associated Malignancies
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Therapeutic Vaccination for HPV-Mediated Cancers
por: Yan, Flora, et al.
Publicado: (2023)

The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes
por: Richards, Kathryn H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_55vba7cpeuhqvsv9g6bgocpjpv